![](/img/cover-not-exists.png)
EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling
Alyse M. DeHaan, Natalie M. Wolters, Evan T. Keller, Kathleen M. Woods IgnatoskiVolume:
69
Year:
2009
Language:
english
Pages:
10
DOI:
10.1002/pros.20903
File:
PDF, 308 KB
english, 2009